Literature DB >> 3286341

Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.

J Karjalainen1, M Knip, H Hyöty, P Leinikki, J Ilonen, M L Käär, H K Akerblom.   

Abstract

In order to elucidate the possible relationship between insulin autoantibodies (IAA), conventional (ICA-IgG) and complement-fixing (CF-ICA) islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies (IgG, IgM and IgA classes), we studied 194 children and adolescents with newly diagnosed Type 1 (insulin-dependent) diabetes. Sixty-one (31.4%) of the subjects were IAA-positive at diagnosis and 73.8% (45/61) of these also had ICA-IgG compared to 51.1% (68/113, p less than 0.01) of IAA-negative children. CF-ICA showed no significant association with IAA. The levels of IAA were significantly higher in the patients with ICA-IgG compared to those without [5.9 +/- 1.6% (SEM) vs 2.5 +/- 0.3%, p less than 0.01]. The patients positive for IAA were younger at diagnosis than the IAA-negative ones; (7.1 +/- 0.5 vs 9.3 +/- 0.3 years, p less than 0.001) and this was also true for ICA-IgG-positive children (8.1 +/- 0.4 vs 9.4 +/- 0.5 years, p less than 0.05) in comparison to ICA-IgG-negative subjects. No significant associations were found between IAA or ICA on the one hand and a positive family history of Type 1 diabetes or metabolic derangements at diagnosis on the other. Subjects negative for ICA were more frequently positive for mumps virus specific IgG antibodies than the ICA-positive patients (50/80 vs 53/111, p less than 0.05), and Coxsackie-B4 virus-specific IgA antibodies were more common in the CF-ICA-negative than the CF-ICA-positive children (53/111 vs 29/80, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286341     DOI: 10.1007/bf00276847

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

Authors:  J E Banatvala; J Bryant; G Schernthaner; M Borkenstein; E Schober; D Brown; L M De Silva; M A Menser; M Silink
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

2.  Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.

Authors:  J Ludvigsson
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

3.  Mumps infection and insulin-dependent diabetes mellitus (IDDM).

Authors:  K P Ratzmann; J Strese; S Witt; H Berling; H Keilacker; D Michaelis
Journal:  Diabetes Care       Date:  1984 Mar-Apr       Impact factor: 19.112

4.  Are insulin autoantibodies markers for insulin-dependent diabetes mellitus?

Authors:  M A Atkinson; N K Maclaren; W J Riley; W E Winter; D D Fisk; R P Spillar
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

5.  Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection.

Authors:  J P Palmer; M K Cooney; R H Ward; J A Hansen; J B Brodsky; C G Ray; J R Crossley; C M Asplin; R H Williams
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

6.  Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.

Authors:  S Srikanta; A T Ricker; D K McCulloch; J S Soeldner; G S Eisenbarth; J P Palmer
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

7.  Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus.

Authors:  H Hyöty; T Huupponen; P Leinikki
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

8.  Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes--a poor predictor of clinical course and antibody response to exogenous insulin.

Authors:  J Karjalainen; M Knip; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

9.  HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects.

Authors:  O Bruserud; J Jervell; E Thorsby
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

10.  Islet-cell antibodies and insulin autoantibodies in association with common viral infections.

Authors:  H J Bodansky; P J Grant; B M Dean; J McNally; G F Bottazzo; M H Hambling; J K Wales
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

View more
  7 in total

1.  No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

Authors:  W A Scherbaum; W Hampl; P Muir; M Glück; J Seissler; H Egle; H Hauner; B O Boehm; E Heinze; J E Banatvala
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

2.  Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice.

Authors:  S Reddy; N Bibby; R B Elliott
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

4.  Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.

Authors:  F K Gorus; J C Sodoyez; D G Pipeleers; B Keymeulen; A Foriers; C F Van Schravendijk
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

5.  Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in northern than in southern Europe.

Authors:  U Samuelsson; J Ludvigsson; G F Bottazzo; M Shattock; S Adolfsson; D Becker; E Cacciari; F Chiarelli; G Chiumello; I Deschamps
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

6.  The status of serum γ-interferonand antiviral antibodies in patients with type I and type 2 diabetes: A comparative study.

Authors:  Zhian M I Dezayee
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

Review 7.  Pathophysiology of diabetes: An overview.

Authors:  Mujeeb Z Banday; Aga S Sameer; Saniya Nissar
Journal:  Avicenna J Med       Date:  2020-10-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.